- Immunocore (NASDAQ:IMCR) is scheduled to announce Q4 earnings results on Wednesday, February 26th, before market open.
- The consensus EPS Estimate is -$0.20 (+50.0% Y/Y) and the consensus Revenue Estimate is $85.78M (+22.3% Y/Y).
- Over the last 3 months, EPS estimates have seen 1 upward revision and 3 downward. Revenue estimates have seen 6 upward revisions and 0 downward.